216 related articles for article (PubMed ID: 11465067)
1. Ornithine aminotransferase, a potential target for the treatment of hyperammonemias.
Seiler N
Curr Drug Targets; 2000 Sep; 1(2):119-53. PubMed ID: 11465067
[TBL] [Abstract][Full Text] [Related]
2. Ornithine aminotransferase activity, liver ornithine concentration and acute ammonia intoxication.
Seiler N; Grauffel C; Daune G; Gerhart F
Life Sci; 1989; 45(11):1009-19. PubMed ID: 2507845
[TBL] [Abstract][Full Text] [Related]
3. DL-canaline and 5-fluoromethylornithine. Comparison of two inactivators of ornithine aminotransferase.
Bolkenius FN; Knödgen B; Seiler N
Biochem J; 1990 Jun; 268(2):409-14. PubMed ID: 2363680
[TBL] [Abstract][Full Text] [Related]
4. Ornithine aminotransferase activity, tissue ornithine concentrations and polyamine metabolism.
Seiler N; Daune G; Bolkenius FN; Knödgen B
Int J Biochem; 1989; 21(4):425-32. PubMed ID: 2501116
[TBL] [Abstract][Full Text] [Related]
5. Aberrations of ammonia metabolism in ornithine carbamoyltransferase-deficient spf-ash mice and their prevention by treatment with urea cycle intermediate amino acids and an ornithine aminotransferase inactivator.
Li MX; Nakajima T; Fukushige T; Kobayashi K; Seiler N; Saheki T
Biochim Biophys Acta; 1999 Sep; 1455(1):1-11. PubMed ID: 10524224
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of ornithine aminotransferase by 5-fluoromethylornithine: protection against acute thioacetamide intoxication by elevated tissue ornithine levels.
Seiler N; Sarhan S; Knödgen B
Pharmacol Toxicol; 1992 May; 70(5 Pt 1):373-80. PubMed ID: 1608926
[TBL] [Abstract][Full Text] [Related]
7. Effects of inhibition of ornithine aminotransferase on thioacetamide-induced hepatogenic encephalopathy.
Sarhan S; Knödgen B; Grauffel C; Seiler N
Neurochem Res; 1993 Apr; 18(4):539-49. PubMed ID: 8474573
[TBL] [Abstract][Full Text] [Related]
8. Protection against lethal ammonia intoxication: synergism between endogenous ornithine and L-carnitine.
Sarhan S; Knoedgen B; Seiler N
Metab Brain Dis; 1994 Mar; 9(1):67-79. PubMed ID: 8058031
[TBL] [Abstract][Full Text] [Related]
9. Effects of ornithine aminotransferase inactivation by 5-fluoromethylornithine in rats following portacaval anastomosis.
Therrien G; Sarhan S; Knödgen B; Butterworth RF; Seiler N
Metab Brain Dis; 1994 Sep; 9(3):211-24. PubMed ID: 7838064
[TBL] [Abstract][Full Text] [Related]
10. Decreased hyperammonaemia and orotic aciduria due to inactivation of ornithine aminotransferase in mice with a hereditary abnormal ornithine carbamoyltransferase.
Seiler N; Grauffel C; Daune-Anglard G; Sarhan S; Knödgen B
J Inherit Metab Dis; 1994; 17(6):691-703. PubMed ID: 7707692
[TBL] [Abstract][Full Text] [Related]
11. 5-Fluoromethylornithine, an irreversible and specific inhibitor of L-ornithine:2-oxo-acid aminotransferase.
Daune G; Gerhart F; Seiler N
Biochem J; 1988 Jul; 253(2):481-8. PubMed ID: 3178724
[TBL] [Abstract][Full Text] [Related]
12. Enhanced endogenous ornithine concentrations protect against tonic seizures and coma in acute ammonia intoxication.
Seiler N; Sarhan S; Knoedgen B; Hornsperger JM; Sablone M
Pharmacol Toxicol; 1993 Feb; 72(2):116-23. PubMed ID: 8097310
[TBL] [Abstract][Full Text] [Related]
13. An orally deliverable ornithine-based self-assembling polymer nanomedicine ameliorates hyperammonemia in acetaminophen-induced acute liver injury.
Ding Y; Koda Y; Shashni B; Takeda N; Zhang X; Tanaka N; Nishikawa Y; Nagasaki Y
Acta Biomater; 2023 Sep; 168():515-528. PubMed ID: 37433359
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic rescue of hyperammonemia-induced toxicity in zebrafish by inhibition of ornithine aminotransferase.
Zielonka M; Breuer M; Okun JG; Carl M; Hoffmann GF; Kölker S
PLoS One; 2018; 13(9):e0203707. PubMed ID: 30199544
[TBL] [Abstract][Full Text] [Related]
15. A new synaptosomal biosynthetic pathway of glutamate and GABA from ornithine and its negative feedback inhibition by GABA.
Yoneda Y; Roberts E; Dietz GW
J Neurochem; 1982 Jun; 38(6):1686-94. PubMed ID: 6122722
[TBL] [Abstract][Full Text] [Related]
16. Ornithine aminotransferase as a therapeutic target in hyperammonemias.
Seiler N
Adv Exp Med Biol; 1997; 420():113-42. PubMed ID: 9286430
[No Abstract] [Full Text] [Related]
17. Some biochemical and pathophysiological aspects of long-term elevation of brain ornithine concentrations.
Daune-Anglard G; Bonaventure N; Seiler N
Pharmacol Toxicol; 1993 Jul; 73(1):29-34. PubMed ID: 8234188
[TBL] [Abstract][Full Text] [Related]
18. Interrelationships between ornithine, glutamate, and GABA. II. Consequences of inhibition of GABA-T and ornithine aminotransferase in brain.
Daune G; Seiler N
Neurochem Res; 1988 Jan; 13(1):69-75. PubMed ID: 2897088
[TBL] [Abstract][Full Text] [Related]
19. Human ornithine aminotransferase complexed with L-canaline and gabaculine: structural basis for substrate recognition.
Shah SA; Shen BW; Brünger AT
Structure; 1997 Aug; 5(8):1067-75. PubMed ID: 9309222
[TBL] [Abstract][Full Text] [Related]
20. Endogenous ornithine in search for CNS functions and therapeutic applications.
Seiler N; Daune-Anglard G
Metab Brain Dis; 1993 Sep; 8(3):151-79. PubMed ID: 8272027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
